Triple

T3542840
Position Surface form Disambiguated ID Type / Status
Subject Jennifer Doudna E74925 entity
Predicate coInvented P1858 FINISHED
Object CRISPR-Cas9 genome-editing method E366097 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: CRISPR-Cas9 genome-editing method | Statement: [Jennifer Doudna, coInvented, CRISPR-Cas9 genome-editing method]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: CRISPR-Cas9 genome-editing method
Context triple: [Jennifer Doudna, coInvented, CRISPR-Cas9 genome-editing method]
  • A. CRISPR-Cas9 gene-editing technology chosen
    CRISPR-Cas9 gene-editing technology is a revolutionary molecular tool that allows scientists to precisely modify DNA within living organisms, transforming research, medicine, and biotechnology.
  • B. A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution
    "A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution" is a popular science book that explains the discovery, science, and ethical implications of CRISPR gene-editing technology for reshaping life and evolution.
  • C. Yamanaka factors
    Yamanaka factors are a set of transcription factors that can reprogram adult somatic cells into induced pluripotent stem cells, revolutionizing regenerative medicine and stem cell research.
  • D. CLARITY tissue-clearing method
    CLARITY is a neuroscience technique that renders biological tissues transparent while preserving their molecular structure, enabling high-resolution, three-dimensional imaging of intact organs such as the brain.
  • E. Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc
    Yamanaka factors Oct3/4, Sox2, Klf4, and c-Myc are a set of transcription factors whose forced expression can reprogram differentiated somatic cells into induced pluripotent stem cells.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ad85d274cc8190ab59c97298a1cfbf completed March 8, 2026, 2:21 p.m.
NER Named-entity recognition batch_69adbf752dd481909226044ffe595338 completed March 8, 2026, 6:27 p.m.
NED1 Entity disambiguation (via context triple) batch_69b3bb8ec8948190a0ae799ad20f42b3 completed March 13, 2026, 7:23 a.m.
Created at: March 8, 2026, 3:20 p.m.